CTOs on the Move


 
League Inc. is reimagining employee health benefits, and is on a mission to empower people to live healthier, happier lives —every day.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.league.com
  • 661 University Avenue Suite 1220
    Toronto, ON CAN M5G1M1
  • Phone: 647.255.1084

Executives

Name Title Contact Details
Mark Finkle
VP of Engineering (Productivity & Developer Program) Profile

Similar Companies

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.

Insightra Medical

Insightra Medical is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pharmaceutical Education and Research Institute Inc

Pharmaceutical Education and Research Institute Inc is a Arlington, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines. We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines. We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies. Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.

Rapid Diagnostek

Rapid Diagnostek is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.